Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Envarsus
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Envarsus 1mg modified-release tablets
0802020T0BJAABC
|
Envarsus | Tacrolimus | Malignant Disease and Immunosuppression | 148 |
|
Envarsus 4mg modified-release tablets
0802020T0BJACBE
|
Envarsus | Tacrolimus | Malignant Disease and Immunosuppression | 73 |
|
Envarsus 750microgram modified-release tablets
0802020T0BJABBD
|
Envarsus | Tacrolimus | Malignant Disease and Immunosuppression | 56 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.